4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Novel Molecular Targets and Innovative Therapeutic Perspective in MedulloblastomaMedulloblastoma, Childhood, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, epithelial neoplasm, glioma, medulloblastoma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumorRecruitingEarly phase 12026-09-03NCT06959979
Liver Steatosis in Pediatric CD PatientsDigestive System Diseases, Nutritional and Metabolic Diseases, celiac disease, digestive system disorder, fatty liver disease, intestinal disorder, liver disorder, malabsorption syndrome, metabolic disease, metabolic dysfunction-associated steatotic liver diseaseRecruitingNot stated2026-05-01NCT06206616
SGLT-2 Inhibitors in the Treatment of AscitesAscites, Digestive System Diseases, Fibrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, diabetes mellitus, endocrine system disorder, glucose metabolism disease, liver disorder, metabolic disease, type 2 diabetes mellitusActive, not recruitingNot stated2026-05-01NCT05999773
Implementing Dynamic Consent for Rare Disease PatientsDisease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare DiseasesNot yet recruitingNot stated2026-04-22NCT06656247